VCYT

|

Veracyte Inc

NASDAQ

USD 26.61
-0.35|-1.30%

Current Price

USD 26.61

Change

USD -0.35 (-1.30%)

P/E Ratio

65.74

Dividend Yield

Market Cap

2.16B

Volume

1.46M

Open

USD 26.73

Previous Close

USD 26.96

52-Week High

USD 47.32

52-Week Low

USD 19.73

About Veracyte Inc
Veracyte Inc logo

Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It is also developing the nCounter analysis system services. The company ...

Sector:Healthcare
Industry:Diagnostics & Research
CEO:Mr. Marc A. Stapley
Employees:824
Headquarters:South San Francisco, USA

Track VCYT and More with ZuneMoney

Get real-time updates, portfolio tracking, and dividend forecasts.

Dividend History
Dividend Payments
Declared DateRecord DatePayment DateAmountFrequency
Similar Companies
Frequently Asked Questions

Track VCYT and More with ZuneMoney

Get real-time updates, portfolio tracking, and dividend forecasts.